血小板GPⅡb/Ⅲa受体拮抗剂在冠心病介入治疗中的临床应用现状
出处
《中国煤炭工业医学杂志》
2009年第8期1318-1320,共3页
Chinese Journal of Coal Industry Medicine
参考文献23
-
1De Queiroz, Fernandes Araujo JQ, VelosoHH, et al. Efficacy and safety of abcixinabbon acute myocardial infarction treated with percutaneous coronary interventions:a meta- analysis of randomized controlled trials[J~]. Am Heart J, 2004,148 (6) 937- 943.
-
2Godicke J, Flather M, NocM, et al. Early versus periprocedural administration of abcixinab for primary angioplasty: a pooled analysis of 6 studies[J].Am Heart J,2005,150 (5): 1015.
-
3Suzuik,Sato K, Kamohara M, et al. Comparative studies of a humanized anti - glycoprotein II b/III a monoclonal antibody, YM337, and abcixiabon invitro antiplatelet effect and binding properties[J]. Biol Pham Bu11,2002,25(8) :1006- 1012.
-
4唐强,霍勇,陈明,李建平,洪涛,郭来敬,王智,张树和,曲华清.盐酸替罗非班对急性心肌梗死急诊经皮冠状动脉介入治疗中TIMI血流影响的临床研究[J].中国介入心脏病学杂志,2006,14(2):97-99. 被引量:86
-
5Patel S, Patal M,Din I, et al. Profound thrombocytopenia associated with tirofiban: case report and review of literature[J]. Angioiogy,2005,56(3) :351.
-
6Corominas N, Perez J, Ortiz J, et al. Tirofihan and eptifibatide treatment of patients presenting with acut coronary syndrome with non- STsegment elevation[J].Parm Word Scj, 2004,26 (1) :38 - 43.
-
7Robert A, Harrington MD. Randomized, Placebo - controlled trial of titrated intravenous lamifiban for acute coronary syndromes[J]. Circulation 2002,105 :316.
-
8De Luca G, Suryapranta H, Stone GW, et al. Abciximab as adjunctive therapy to reperfuslon in acute ST- segment elevation myocardial infarction: A meta- analysis of randomized trials[J]. JAM.A,2005,293 (14):1759 - 1765.
-
9Lavi S,Gruberg L, Kapeliovich M,et al. The impact of GP II b/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients[J]. J Invasive Cardio,2005,17(6):296- 299.
-
10IMPACT- IT Investigators. Randomizde placebo- controlled trial of effect of eptifibatide on complications of pereutaneous coronary intervention: IMPACT - II [J]. Lancet, 1997, 349 : 1422.
二级参考文献4
-
1Lefkovitz J,Plow EF,Topol EJ.Platelet glycoprotein Ⅱb/Ⅲa receptor in cardiovascular medicine.N Engl J Med,1995,332:1553-1558.
-
2Montalescot G,Barragan P,Wittenbery O,et al.For the ADMIRAL investigators.Platelet glycopretion Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction.N Eng J Med,2001,21:1895-1903.
-
3Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition with tirofiban before primary angioplasty improves angiographic outcome:Results of the Tirofiban give in the Emergency Room before primary angioplasty (TIGER-PA) pilot trial.Circulation,2003,107:1497-1501.
-
4The TIMI study group.The thrombolysis in myocardial infarction (TIMI) trial;phase I findings.N Engl J Med,1985,312:932-936.
共引文献85
-
1李志娟,董平栓,杨旭明,王绍欣,王红雷,王可,杜来景,李转珍,尚喜艳,范喜梅.急性心肌梗死患者PCI术中冠脉内注射替罗非班对TIMI血流的影响[J].中国心血管病研究,2009,7(7):491-493. 被引量:2
-
2高智耀,高峰,马小川,刘兆英,常文雄,刘卫生,李哓莉,兰艳丽.血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂对急性冠脉综合征PCI术中的安全性和有效性[J].延安大学学报(医学科学版),2009,7(4):11-13.
-
3唐强,郭来敬,张树和,王智,曲华清,颜东,唐群中,史震涛.盐酸替罗非班在ST段抬高急性心肌梗死急诊PCI中的安全性分析[J].心肺血管病杂志,2007,26(1):21-23. 被引量:27
-
4尹秋林,洪浪,王洪,李彬,李林锋.急性心肌梗死介入治疗中冠脉内注射替罗非班对TIMI血流的影响[J].实用临床医学(江西),2007,8(2):79-80. 被引量:5
-
5王鹏武,洪浪,尹秋林.冠脉内注射欣维宁对CMI介入治疗TIMI血流的影响[J].白求恩军医学院学报,2007,5(3):169-170.
-
6徐立,杨新春,王乐丰,葛永贵,王红石,李惟铭,陈牧雷,崔亮.急性心肌梗死急诊介入治疗联合应用替罗非班发生血小板减少症的临床分析——替罗非班可能的副作用[J].中国介入心脏病学杂志,2008,16(1):5-7. 被引量:25
-
7谢绍峰,李忠红,朱恒青,钟湧辉,刘伟斌,谢正,李锦梅.国产雷帕霉素药物洗脱支架置入治疗急性ST段抬高心肌梗死:与进口药物支架比较其安全性和有效性[J].中国组织工程研究与临床康复,2008,12(4):615-618. 被引量:2
-
8李志娟,张薇,董平栓,刘孝民.急性心肌梗死患者介入术中冠脉内应用替罗非班的疗效和安全性评价[J].陕西医学杂志,2008,37(4):425-427. 被引量:22
-
9黄春艳,买苏木.国产替罗非班对急性冠脉综合征行PCI术患者的临床疗效分析[J].新疆医学,2008,38(4):10-13. 被引量:1
-
10任丽霞,乔福斌,张郁.盐酸替罗非班联合低分子肝素治疗不稳定型心绞痛50例[J].中国药业,2008,17(11):70-71. 被引量:5
-
1高爱宝,贺继忠.直接冠脉内注射GpⅡb/Ⅲa受体拮抗剂对STEMI患者PCI治疗后无再流、慢再流的防治[J].实用临床医药杂志,2015,19(17):8-10. 被引量:1
-
2赵依农,吾红光,邱慧卿,杨淳英,郑彦.替罗非班治疗急性冠脉综合征临床观察[J].心脑血管病防治,2008,8(4):241-242. 被引量:1
-
3李芳,王琳,卜军.替罗非班治疗急性冠脉综合征的临床研究[J].内科急危重症杂志,2004,10(2):72-74. 被引量:17
-
4刘强,王丽丽,龙娟,衣为民,翁建新,魏熠.盐酸替罗非班在急性心肌梗死急诊PCI中的疗效及安全性[J].中西医结合心脑血管病杂志,2010,8(3):357-358. 被引量:2
-
5窦庆山.替罗非班在急性心肌梗塞行PCI治疗中无复流现象的临床应用[J].内蒙古医学杂志,2010,42(S6):14-16.
-
6时占楼,张湘华,冯燕光,张文亮,薛铮,吴琳,骆海霞.国产替罗非班对急性冠脉综合症患者临床症状的影响[J].中国医药导刊,2008,10(4):562-563. 被引量:4
-
7陈金国,杨体霞,沈童童,周利民,陶春明,张军,王东平,王三刚,李峰.盐酸替罗非班在急性ST段抬高型心肌梗死介入治疗中的有效性及安全性探讨[J].皖南医学院学报,2011,30(6):483-485. 被引量:7
-
8朱文玲.GPⅡb/Ⅲa受体拮抗剂在急性冠状动脉综合征中的应用[J].引进国外医药技术与设备,1999,5(7):25-27.
-
9夏豪,谭安安,周桃,胡波.盐酸替罗非班对急性冠脉综合征梗死相关血管TIMI血流的影响[J].心脏杂志,2008,20(1):49-50. 被引量:1
-
10林德智,张晓东,倪卫,廖锐,杨勇.急性心肌梗死急诊介入治疗对心功能的影响[J].中西医结合心血管病电子杂志,2014,2(9):91-91.